Inflammasome Therapeutics, Inc. research brief
CIK 1989925
Generated Nov. 19, 2026, 11:35 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: NEWTON Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- May 4, 2026 · D · 0001989925-26-000003 · Source evidence
Reported offering amount: 13155645 USD. Reported amount sold: 13155645 USD.
- March 17, 2025 · D · 0002060536-25-000002 · Source evidence
Reported offering amount: 10000000 USD. Reported amount sold: 2450172 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Inflammasome Therapeutics, Inc. research brief,” CIK 1989925, retrieved Nov. 19, 2026, 11:35 a.m.. Cite the specific accessions used. No amounts have been summed.